<VariationArchive VariationID="1431411" VariationName="NM_014956.5(CEP164):c.2942_2943del (p.Glu981fs)" VariationType="Deletion" Accession="VCV001431411" Version="4" RecordType="classified" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2024-02-28" DateCreated="2022-03-28" MostRecentSubmission="2024-02-28">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="1490709" VariationID="1431411">
      <GeneList>
        <Gene Symbol="CEP164" FullName="centrosomal protein 164" GeneID="22897" HGNC_ID="HGNC:29182" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>11q23.3</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="11" Accession="NC_000011.10" start="117321778" stop="117413266" display_start="117321778" display_stop="117413266" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="11" Accession="NC_000011.9" start="117198570" stop="117283981" display_start="117198570" display_stop="117283981" Strand="+" />
          </Location>
          <OMIM>614848</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_014956.5(CEP164):c.2942_2943del (p.Glu981fs)</Name>
      <CanonicalSPDI>NC_000011.10:117395573:GAG:G</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>11q23.3</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="11" Accession="NC_000011.10" start="117395574" stop="117395575" display_start="117395574" display_stop="117395575" variantLength="2" positionVCF="117395573" referenceAlleleVCF="GGA" alternateAlleleVCF="G" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="11" Accession="NC_000011.9" start="117266290" stop="117266291" display_start="117266290" display_stop="117266291" variantLength="2" positionVCF="117266289" referenceAlleleVCF="GGA" alternateAlleleVCF="G" />
      </Location>
      <ProteinChange>E981fs</ProteinChange>
      <ProteinChange>E984fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000011.10" sequenceAccession="NC_000011" sequenceVersion="10" change="g.117395575_117395576del" Assembly="GRCh38">
            <Expression>NC_000011.10:g.117395575_117395576del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000011.9" sequenceAccession="NC_000011" sequenceVersion="9" change="g.117266291_117266292del" Assembly="GRCh37">
            <Expression>NC_000011.9:g.117266291_117266292del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_033032.1" sequenceAccession="NG_033032" sequenceVersion="1" change="g.78798_78799del">
            <Expression>NG_033032.1:g.78798_78799del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001271933.2" sequenceAccession="NM_001271933" sequenceVersion="2" change="c.2951_2952del">
            <Expression>NM_001271933.2:c.2951_2952del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001258862.1" sequenceAccession="NP_001258862" sequenceVersion="1" change="p.Glu984fs">
            <Expression>NP_001258862.1:p.Glu984fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_014956.5" sequenceAccession="NM_014956" sequenceVersion="5" change="c.2942_2943del" MANESelect="true">
            <Expression>NM_014956.5:c.2942_2943del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_055771.4" sequenceAccession="NP_055771" sequenceVersion="4" change="p.Glu981fs">
            <Expression>NP_055771.4:p.Glu981fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="rs" ID="2136450623" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_014956.5(CEP164):c.2942_2943del (p.Glu981fs) AND Nephronophthisis 15" Accession="RCV001948653" Version="3">
        <ClassifiedConditionList TraitSetID="8926">
          <ClassifiedCondition DB="MedGen" ID="C3541853">Nephronophthisis 15</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2021-12-13" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2021-12-13" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2022-03-28" MostRecentSubmission="2024-02-28">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">22863007</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">28125082</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">32367404</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">34132027</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">34499853</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="8926" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="17403" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Nephronophthisis 15</ElementValue>
                <XRef ID="MONDO:0013917" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">NPHP15</ElementValue>
                <XRef Type="MIM" ID="614845" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">The nephronophthisis (NPH) phenotype is characterized by reduced renal concentrating ability, chronic tubulointerstitial nephritis, cystic renal disease, and progression to end-stage renal disease (ESRD) before age 30 years. Three age-based clinical subtypes are recognized: infantile, juvenile, and adolescent/adult. Infantile NPH can present in utero with oligohydramnios sequence (limb contractures, pulmonary hypoplasia, and facial dysmorphisms) or postnatally with renal manifestations that progress to ESRD before age 3 years. Juvenile NPH, the most prevalent subtype, typically presents with polydipsia and polyuria, growth retardation, chronic iron-resistant anemia, or other findings related to chronic kidney disease (CKD). Hypertension is typically absent due to salt wasting. ESRD develops at a median age of 13 years. Ultrasound findings are increased echogenicity, reduced corticomedullary differentiation, and renal cysts (in 50% of affected individuals). Histologic findings include tubulointerstitial fibrosis, thickened and disrupted tubular basement membrane, sporadic corticomedullary cysts, and normal or reduced kidney size. Adolescent/adult NPH is clinically similar to juvenile NPH, but ESRD develops at a median age of 19 years. Within a subtype, inter- and intrafamilial variability in rate of progression to ESRD is considerable. Approximately 80%-90% of individuals with the NPH phenotype have no extrarenal features (i.e., they have isolated NPH); ~10%-20% have extrarenal manifestations that constitute a recognizable syndrome (e.g., Joubert syndrome, Bardet-Biedl syndrome, Jeune syndrome and related skeletal disorders, Meckel-Gruber syndrome, Senior-LÃ¸ken syndrome, Leber congenital amaurosis, COACH syndrome, and oculomotor apraxia, Cogan type).</Attribute>
                <XRef ID="NBK368475" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="15852" />
                <XRef ID="15852" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">27336129</ID>
                <ID Source="BookShelf">NBK368475</ID>
              </Citation>
              <XRef ID="3156" DB="Orphanet" />
              <XRef ID="C3541853" DB="MedGen" />
              <XRef ID="MONDO:0013917" DB="MONDO" />
              <XRef Type="MIM" ID="614845" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="4232356" SubmissionDate="2024-02-07" DateLastUpdated="2024-02-28" DateCreated="2022-03-28">
        <ClinVarSubmissionID localKey="13980892|MedGen:C3541853" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002210364" DateUpdated="2024-02-28" DateCreated="2022-03-28" Type="SCV" Version="3" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2021-12-13">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">22863007</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">28125082</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">32367404</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">34132027</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">34499853</ID>
          </Citation>
          <Comment>For these reasons, this variant has been classified as Pathogenic. This variant has not been reported in the literature in individuals affected with CEP164-related conditions. This variant is not present in population databases (gnomAD no frequency). This sequence change creates a premature translational stop signal (p.Glu981Glyfs*21) in the CEP164 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in CEP164 are known to be pathogenic (PMID: 22863007, 28125082, 32367404, 34132027, 34499853).</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="CEP164" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000011.9:g.117266290_117266291del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C3541853" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB11173117</SubmissionName>
          <SubmissionName>SUB12506961</SubmissionName>
          <SubmissionName>SUB14200269</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="4232356" TraitType="Disease" MappingType="XRef" MappingValue="C3541853" MappingRef="MedGen">
        <MedGen CUI="C3541853" Name="Nephronophthisis 15" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

